Evidence map›Paper›PMID 42110046›Full record

ArticleCureus2026

Upper Extremity Deep Vein Thrombosis Secondary to Gastric Cancer: A Case Report.

Maimi Takano, Takuya Otsuki, Kosuke Ishizuka, Iori Motohashi, Kenya Ie, Chiaki Okuse

Abstract readCase Reports
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Maimi TakanoDepartment of General Internal Medicine, St. Marianna University School of Medicine, Kawasaki, JPN.
Takuya OtsukiDepartment of General Internal Medicine, St. Marianna University School of Medicine, Kawasaki, JPN.
Kosuke IshizukaDepartment of General Medicine, Yokohama City University School of Medicine, Yokohama, JPN.
Iori MotohashiDepartment of General Internal Medicine, St. Marianna University School of Medicine, Kawasaki, JPN.
Kenya IeDepartment of General Internal Medicine, St. Marianna University School of Medicine, Kawasaki, JPN.
Chiaki OkuseDepartment of General Internal Medicine, St. Marianna University School of Medicine, Kawasaki, JPN.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Upper extremity deep vein thrombosis (UEDVT) is uncommon and is frequently secondary to malignancy, central venous catheterization, or hypercoagulable states. Cancer‑associated thrombosis represents a major cause of morbidity and mortality in patients with malignancy. A 75‑year‑old Japanese woman presented with swelling of the left upper extremity accompanied by epigastric discomfort. Contrast‑enhanced computed tomography revealed thrombosis in the left subclavian vein and multiple metastatic lesions, including hepatic hilar lymph node and spinal metastases. Esophagogastroduodenoscopy demonstrated irregular mucosa with erosions from the gastric angle to the antrum, and pathological examination confirmed poorly to moderately differentiated adenocarcinoma with signet‑ring cell features. The patient was diagnosed with UEDVT secondary to gastric cancer. Anticoagulation therapy with unfractionated heparin improved swelling and pain, and the patient was transitioned to oral apixaban. Chemotherapy was subsequently initiated; however, the patient died nine months after diagnosis due to disease progression. This case highlights the importance of investigating occult malignancy in patients presenting with unexplained venous thromboembolism and initiating prompt anticoagulation therapy.

Indexed as

cancer-associated thrombosisdeep vein thrombosisgastric cancertrousseau syndromeupper extremity thrombosis

Identifiers

PMID42110046
PMCPMC13154107

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.